Stockreport

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency [Yahoo! Finance]

Virax Biolabs Group Limited  (VRAX) 
PDF focused on the detection of immune responses and diagnosis of viral diseases, announced that it received a notice from The Nasdaq Stock Market LLC ("Nasdaq") dated March [Read more]